Abstract
An analytical method was developed for estimation of Emtricitabine and Tenofovir Disoproxil Fumarate in drug product by using high performance liquid chromatography. The chromatographic separation was performed on column Cosmosil C18 (250mm x 4.6ID, Particle size: 5micron) using methanol: water (70:30 v/v) as mobile phase with flow rate of 0.8 ml/min. The detection was carried by using UV-300-M detector at 266 nm wavelength. The retention times of Emtricitabine and Tenofovir Disoproxil Fumarate were found to be 3.561 and 5.478 min respectively. Run time was observed as 5.54 min and 7.05 min respectively for Emtricitabine and Tenofovir Disoproxil Fumarate. Validation was performed as per ICH guidelines which include accuracy, precision, linearity, specificity, LOD, LOQ, ruggedness and robustness all of these were found within standard range as per ICH norms. Preparation of mobile phase is very simple & does not require lengthy procedure. Proposed method was found to be accurate and specific for routine quality control of pharmaceutical dosage form like bulk and tablet dosage form. Keywords: Emtricitabine, Tenofovir Disoproxil Fumarate, HPLC, Validation.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
